Biofrontera Financial Overview
Biofrontera's market cap is currently $8.58M. The company's EPS TTM is $-0.62; its P/E ratio is -0.39; Biofrontera is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $0.15. See an overview of income statement, balance sheet, and cash flow financials.
